Bullish on Oncology Drug Potential? This Biotech Fund Increases Stake in Enliven Therapeutics May 13, 2026 Life Science
Hantavirus Fears Fuel Moderna Rally: Is This a Real Catalyst or Just Sentiment? May 11, 2026 Life Science
Eli Lilly Stock Hits Bottleneck After 400% Surge in Five Years, Novo Nordisk Poised for a Comeback with 4% Dividend Yield May 8, 2026 Life Science
As Summer Approaches, These TSX Stocks May Be Worth Positioning in Advance May 8, 2026 Mining, Precious Metals
Quarterly Sales Reach $8.7 Billion, Eli Lilly’s Mounjaro Becomes New Blockbuster Drug King May 6, 2026 Life Science
Eli Lilly’s Alzheimer’s Drug Kisunla Wins Health Canada Approval, Bolstering Global Footprint May 4, 2026 Life Science
Stock Isn’t Cheap but Still Worth Buying? Three Hard Reasons Behind Eli Lilly Explained May 4, 2026 Life Science
Dark Horse in the Weight-Loss Drug Arena? Viking Therapeutics Has Potential Upside of Over 200% May 4, 2026 Life Science
Want to Build Real Wealth in the Healthcare Sector? These Stocks Are Worth Considering Apr 30, 2026 Life Science
Shorted-to-The-Hilt KalVista Rockets 39% as Chiesi Swoops in With $1.9bn Cash Bid Apr 29, 2026 Life Science
From Weight Loss to Cancer Treatment Drugs, Eli Lilly Has More Than One Ace in the Hole Apr 28, 2026 Life Science
Organon Shares Extend Rally as India’s Sun Pharma Strikes $11.75 Billion All-Cash Deal Apr 27, 2026 Life Science
